OncoSec Medical Incorporated Press Releases

ONCS 
$0.609
*  
0.0079
1.31%
Get ONCS Alerts
*Delayed - data as of Jul. 9, 2014  -  Find a broker to begin trading ONCS now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

OncoSec Medical To Present at Bioelectrochemistry Gordon Research Conference on July 8 and July 10
7/2/2014 6:02:00 AM - Business Wire

OncoSec Medical Appoints Dr. Soldano Ferrone to Scientific Advisory Board
6/25/2014 6:02:00 AM - Business Wire

OncoSec Medical Announces YTD Results as of April 30, 2014
6/13/2014 9:00:00 AM - Business Wire

OncoSec Medical Issues Annual Letter To Shareholders
6/12/2014 6:03:00 AM - Business Wire

OncoSec Medical Closes $16 Million Registered Direct Offering
6/10/2014 6:03:00 AM - Business Wire

OncoSec Medical Announces $16 Million Registered Direct Offering
6/4/2014 9:00:00 AM - Business Wire

OncoSec Medical to Present at LD Micro 4th Invitational
6/3/2014 6:02:00 AM - Business Wire

OncoSec Medical Presents Positive Phase 2 Interim Data Evaluating ImmunoPulse in Melanoma
6/2/2014 9:31:00 AM - Business Wire

OncoSec Medical To Present at Four Events in June
5/27/2014 6:03:00 AM - Business Wire

OncoSec Medical To Present At The Third Annual Marcum MicroCap Conference
5/13/2014 6:03:00 AM - PR Newswire

OncoSec Medical Presents New Data at 10th Annual PEGS: The Essential Protein Engineering Summit in Boston
5/5/2014 6:15:00 AM - Business Wire

OncoSec Medical to Present at Seven Events in May
4/28/2014 6:03:00 AM - Business Wire

OncoSec Medical Names Adil Daud, M.D. as Chief Clinical Strategist
4/23/2014 6:03:00 AM - Business Wire

OncoSec Medical Selected to Present Phase II Data in Poster Highlights Session at 2014 ASCO Annual Meeting
4/22/2014 6:02:00 AM - Business Wire